{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:16:28Z","timestamp":1790493388486,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.diii.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T00:21:35Z","timestamp":1522455695000},"page":"527-535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Transarterial chemoembolization (TACE) in the management of hepatocellular carcinoma: Results of a French national survey on current practices"],"prefix":"10.1016","volume":"99","author":[{"given":"A.","family":"Fohlen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Tasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kobeiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Pelage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2018.03.003_bib0205","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2018.03.003_bib0210","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.diii.2018.03.003_bib0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.clinre.2016.01.007","article-title":"Interventional oncology for hepatocellular carcinoma","volume":"40","author":"Delicque","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.diii.2018.03.003_bib0220","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ajg.2014.152","article-title":"Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2cm or smaller","volume":"109","author":"Kim","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diii.2018.03.003_bib0225","doi-asserted-by":"crossref","first-page":"18715","DOI":"10.18632\/oncotarget.4134","article-title":"Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.diii.2018.03.003_bib0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejrad.2010.12.058","article-title":"Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function","volume":"81","author":"Hsu","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0235","doi-asserted-by":"crossref","first-page":"e89081","DOI":"10.1371\/journal.pone.0089081","article-title":"The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients","volume":"9","author":"Xie","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.diii.2018.03.003_bib0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/CAD.0b013e328346a0c5","article-title":"Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma","volume":"22","author":"Boulin","year":"2011","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.diii.2018.03.003_bib0245","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00270-016-1319-0","article-title":"Which is the best chemotherapeutic agent for transarterial chemoembolization of hepatocellular carcinoma?","volume":"39","author":"Boulin","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials","volume":"224","author":"Camm\u00e0","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2018.03.003_bib0255","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2018.03.003_bib0260","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.diii.2018.03.003_bib0265","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00270-016-1535-7","article-title":"Chemoembolization of neuroendocrine liver metastases using streptozocin and tris-acryl microspheres: Embozar (EMBOsphere+ZAnosaR) study","volume":"40","author":"Pelage","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0275","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00270-012-0423-z","article-title":"Quality-improvement guidelines for hepatic transarterial chemoembolization","volume":"35","author":"Basile","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0280","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.jvir.2009.04.033","article-title":"Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy","volume":"20","author":"Brown","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0285","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00270-013-0656-5","article-title":"Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology","volume":"37","author":"Bargellini","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0290","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00270-016-1299-0","article-title":"The provision of interventional radiology services in Europe: CIRSE recommendations","volume":"39","author":"Tsetis","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0295","doi-asserted-by":"crossref","first-page":"32190","DOI":"10.18632\/oncotarget.12921","article-title":"Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation","volume":"8","author":"Hocquelet","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.diii.2018.03.003_bib0300","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ctrv.2010.07.006","article-title":"Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization","volume":"37","author":"Raoul","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.diii.2018.03.003_bib0305","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00330-016-4445-9","article-title":"Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization","volume":"27","author":"Gorodetski","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0310","doi-asserted-by":"crossref","first-page":"10327","DOI":"10.3748\/wjg.v21.i36.10327","article-title":"Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system","volume":"21","author":"Han","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.diii.2018.03.003_bib0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/liv.12713","article-title":"Treatment of hepatocellular carcinoma: beyond international guidelines","volume":"35","author":"Colombo","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.diii.2018.03.003_bib0320","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1097\/01.RVI.0000244854.79604.C1","article-title":"Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention","volume":"17","author":"Patel","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0325","doi-asserted-by":"crossref","first-page":"W343","DOI":"10.2214\/AJR.10.6019","article-title":"Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study","volume":"197","author":"Khan","year":"2011","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.diii.2018.03.003_bib0330","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00270-008-9468-4","article-title":"Usefulness of cone-beam computed tomography during ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinomas that cannot be demonstrated on angiography","volume":"32","author":"Miyayama","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0335","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11604-012-0088-1","article-title":"Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?","volume":"30","author":"Yamakado","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0033-1333648","article-title":"Chemoembolization of hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2013","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0345","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of liver tumors with Lipiodol TACE: technical recommendations from experts opinion","volume":"39","author":"de Baere","year":"2016","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0350","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.diii.2017.10.010","article-title":"Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma","volume":"98","author":"Matsui","year":"2017","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2018.03.003_bib0355","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.diii.2018.03.003_bib0360","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2011.09.012","article-title":"Liver\/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads","volume":"56","author":"Guiu","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.diii.2018.03.003_bib0365","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00330-016-4488-y","article-title":"Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion","volume":"27","author":"Monier","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0370","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.diii.2015.04.005","article-title":"Transarterial chemoembolization for hepatocellular carcinoma: an old method, now flavor of the day","volume":"96","author":"Boulin","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2018.03.003_bib0375","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jvir.2008.10.019","article-title":"Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5cm","volume":"20","author":"Takaki","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0380","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/j.crad.2014.01.015","article-title":"Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?","volume":"69","author":"Zheng","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.diii.2018.03.003_bib0385","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.diii.2018.03.003_bib0390","first-page":"7247","article-title":"Comparison of two transarterial chemoembolization strategies for hepatocellular carcinoma","volume":"34","author":"Tavernier","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.diii.2018.03.003_bib0395","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/annonc\/mds605","article-title":"mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)","volume":"24","author":"Prajapati","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.diii.2018.03.003_bib0400","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diii.2016.09.002","article-title":"Evaluation of tumor response to intra-arterial chemoembolization of hepatocellular carcinoma: comparison of contrast-enhanced ultrasound with multiphase computed tomography","volume":"98","author":"Paul","year":"2017","journal-title":"Diagn Interv Imaging"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568418300706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568418300706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T17:07:46Z","timestamp":1604077666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568418300706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2211568418300706"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2018.03.003","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial chemoembolization (TACE) in the management of hepatocellular carcinoma: Results of a French national survey on current practices","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 fran\u00e7aise de radiologie. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}